India Globalization Capital, Inc. (NYSE: IGC) Growth Potential Fueled by Phytocannabinoid Treatments
Hyalolex for Alzheimer’s and other cannabis-based drugs for pain, epilepsy, and more are raising the market valuation growth potential for IGC Phytocannabinoids target protein receptors in the brain, peripheral nervous system and other parts of the body, including the lungs, liver, and other organs Cannabidiol makes up as much as 40 percent of cannabis-plant extract and has more potential medical uses than THC Cannabinoid receptors have been known in the medical community since 1988. India Globalization Capital, Inc. (NYSE MKT: IGC) is the first company to develop revolutionary cannabis-based pharmaceuticals targeting Alzheimer’s. Based on this alone, the company's market valuation…







